A once-promising vaccine for AIDS may have inadvertently increased the infection risk of people participating in clinical trials, researchers said on Wednesday.
The multinational trials involving more than 3,000 HIV-negative volunteers were canceled last month after a large-scale study found it was not effective at preventing infection.
Further analysis showed that those who received the vaccine had a higher rate of infection than those who received a placebo, said US pharmaceutical giant Merck, which helped develop the vaccine.
The study volunteers who received the vaccine are being advised of their potentially increased susceptibility, Merck said.
"We are analyzing the data to try to determine if the results are due to immune responses induced by the vaccine, differences in study populations, or some other biological phenomenon we don't yet understand, or simply due to chance," said Keith Gottesdiener, vice president of Merck's vaccine and infectious disease clinical research.
"It will take some time before we understand why the vaccine did not work and why there was a trend toward more cases of infection in volunteers who received the vaccine," he said in a statement.
The experimental vaccine cannot cause infection, Merck said.
It was a modified cold virus used to deliver three synthetically produced HIV genes in the hopes of stimulating a response from the immune system.
Unlike earlier failed vaccines which tried to get the immune system to produce antibodies, the V520 vaccine stimulated T cells, the main disease fighters of the body.
These are the cells that HIV infects and uses to replicate itself, leading to a drop in the number of T cells available to fight off other infections.
It's possible that the volunteers became more vulnerable to HIV infection because the vaccine stimulates an increase in the production of T cells, a spokeswoman said.
The randomized, double-blind trials were conducted in various sites in the US, Canada, Peru, Brazil, Dominican Republic, Haiti, Puerto Rico, Jamaica, Australia and South Africa beginning in 2004.
Volunteers, who were already at high-risk of contracting AIDS, were given prevention counseling in addition to the vaccine or placebo. But dozens became infected anyway.
All but one of the infections among those given the vaccine were in male volunteers and the bulk of those infected were homosexual men.
Those with a higher level of pre-existing immunity to the modified cold virus used to deliver the vaccine were twice as likely to have been infected if they received the vaccine.
The initial analysis found 21 cases of HIV infection among the 392 men who received the vaccine while only nine cases were reported among the 386 men with a high level of pre-existing immunity who were given a placebo.
The results are "both disappointing and puzzling," said Anthony Fauci, the director of the US National Institute of Allergy and Infectious Diseases, which co-sponsored the trials.
"Certainly, the failure of this HIV vaccine product was unexpected," he said in a statement.
"But this setback should not and can not diminish our commitment to developing an effective HIV vaccine."
About 12,000 people become infected with HIV every day and vaccines have historically been the most effective tool against infections diseases like polio and smallpox.
While scientists work on developing a vaccine, politicians need to implement proven prevention methods, Fauci said.
Eleven people, including a former minister, were arrested in Serbia on Friday over a train station disaster in which 16 people died. The concrete canopy of the newly renovated station in the northern city of Novi Sad collapsed on Nov. 1, 2024 in a disaster widely blamed on corruption and poor oversight. It sparked a wave of student-led protests and led to the resignation of then-Serbian prime minister Milos Vucevic and the fall of his government. The public prosecutor’s office in Novi Sad opened an investigation into the accident and deaths. In February, the public prosecutor’s office for organized crime opened another probe into
RISING RACISM: A Japanese group called on China to assure safety in the country, while the Chinese embassy in Tokyo urged action against a ‘surge in xenophobia’ A Japanese woman living in China was attacked and injured by a man in a subway station in Suzhou, China, Japanese media said, hours after two Chinese men were seriously injured in violence in Tokyo. The attacks on Thursday raised concern about xenophobic sentiment in China and Japan that have been blamed for assaults in both countries. It was the third attack involving Japanese living in China since last year. In the two previous cases in China, Chinese authorities have insisted they were isolated incidents. Japanese broadcaster NHK did not identify the woman injured in Suzhou by name, but, citing the Japanese
YELLOW SHIRTS: Many protesters were associated with pro-royalist groups that had previously supported the ouster of Paetongtarn’s father, Thaksin, in 2006 Protesters rallied on Saturday in the Thai capital to demand the resignation of court-suspended Thai Prime Minister Paetongtarn Shinawatra and in support of the armed forces following a violent border dispute with Cambodia that killed more than three dozen people and displaced more than 260,000. Gathered at Bangkok’s Victory Monument despite soaring temperatures, many sang patriotic songs and listened to speeches denouncing Paetongtarn and her father, former Thai prime minister Thaksin Shinawatra, and voiced their backing of the country’s army, which has always retained substantial power in the Southeast Asian country. Police said there were about 2,000 protesters by mid-afternoon, although
MOGAMI-CLASS FRIGATES: The deal is a ‘big step toward elevating national security cooperation with Australia, which is our special strategic partner,’ a Japanese official said Australia is to upgrade its navy with 11 Mogami-class frigates built by Japan’s Mitsubishi Heavy Industries, Australian Minister for Defence Richard Marles said yesterday. Billed as Japan’s biggest defense export deal since World War II, Australia is to pay US$6 billion over the next 10 years to acquire the fleet of stealth frigates. Australia is in the midst of a major military restructure, bolstering its navy with long-range firepower in an effort to deter China. It is striving to expand its fleet of major warships from 11 to 26 over the next decade. “This is clearly the biggest defense-industry agreement that has ever